A detailed history of Voya Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Voya Investment Management LLC holds 80,941 shares of NVO stock, worth $6.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80,941
Previous 158,358 48.89%
Holding current value
$6.88 Million
Previous $22.6 Million 57.37%
% of portfolio
0.01%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $9.22 Million - $11.3 Million
-77,417 Reduced 48.89%
80,941 $9.64 Million
Q2 2024

Dec 03, 2024

BUY
$122.71 - $146.91 $9.5 Million - $11.4 Million
77,417 Added 95.65%
158,358 $22.6 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $3.8 Million - $4.55 Million
30,998 Added 24.34%
158,358 $22.6 Million
Q1 2024

Dec 06, 2024

BUY
$102.11 - $135.92 $4.74 Million - $6.31 Million
46,419 Added 57.35%
127,360 $16.4 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $6.94 Million - $9.23 Million
67,920 Added 114.27%
127,360 $16.4 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $1.06 Million - $1.28 Million
-12,100 Reduced 16.91%
59,440 $6.15 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $3.69 Million - $8.09 Million
40,535 Added 130.74%
71,540 $6.51 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $1 Million - $1.11 Million
-6,430 Reduced 17.18%
31,005 $5.02 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $76,095 - $91,505
575 Added 1.56%
37,435 $5.96 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $772,714 - $1.02 Million
7,535 Added 25.69%
36,860 $4.99 Million
Q3 2022

Mar 03, 2023

SELL
$95.28 - $116.93 $717,934 - $881,067
-7,535 Reduced 20.44%
29,325 $2.92 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $2.79 Million - $3.43 Million
29,325 New
29,325 $2.92 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.